Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.

Oncology (Williston Park, N.Y.)

Volumn 19, Issue 4 Suppl 2, 2005, Pages 5-9

  Disis, Mary L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; HUMAN; MELANOMA; NEOPLASM; NEUTROPENIA; PATHOPHYSIOLOGY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FILGRASTIM; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MELANOMA; NEOPLASMS; NEUTROPENIA;

EID: 23444454209     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)